Viewing Study NCT02848794


Ignite Creation Date: 2025-12-25 @ 1:45 AM
Ignite Modification Date: 2026-03-11 @ 10:28 PM
Study NCT ID: NCT02848794
Status: UNKNOWN
Last Update Posted: 2017-06-16
First Post: 2016-07-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Apatinib and Irinotecan in Treating Patients With Recurrent High-grade Glioma
Sponsor: The First People's Hospital of Lianyungang
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: AI-001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER View
None UNKNOWN View
None OTHER View
None UNKNOWN View